ReviewCancer drug resistance (Alhambra, Calif.)2021

The HGF/c-MET axis as a potential target to overcome survival signals and improve therapeutic efficacy in multiple myeloma.

Paolo Giannoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.